Disability Related Feature Stories and Live Breaking News

Disability Nexus

Subscribe to Disability Nexus : eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Disability Nexus : homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories

SALT LAKE CITY, Jan. 15, 2013 /PRNewswire/ -- Lineagen, Inc. today announced publication of the results of a 9,000-person genetic study that demonstrates an approximately 100% increase in the detection rate of genetic markers now validated as being associated with autism spectrum disorders (ASDs).  The study, one of the largest genetic validation studies in autism, was designed to confirm novel copy number genetic variants and novel next-generation sequence variants associated with ASDs.  Researchers affiliated with The Children's Hospital of Philadelphia (CHOP), the University of Utah (Utah), Golden Helix, Inc, and Lineagen have confirmed in family and broad population studies a two-fold increase in the number of cases of ASD that can be ascribed to these newly identified genetic variants, specifically gene deletions or duplications (termed copy number variants, or... (more)

About Disability Resource Exchange Social Network

I created and manage a social network for discussion of disability issues. The website address is: http://www.disabilityresourceexchange.com About the disability resource exchange Disability resource exchange is a place to discuss disability issues and exchange resources ideas and support. whether you have a disability/health issue or are just interested in disability issues you are welcome to join this social network. The disability resource exchange mission - to bring together all those interested in disability issues both people with and without disabilities - to bring together people and organizations within the disability community and to foster a spirit of cooperation - To be a place with a supportive atmosphere where we can all learn from each other Again anyone interested in disability issues is welcome to join. I hope to see you there :-) http://www.disabili... (more)

Loss and finding the right wheelchair

Nov. 24, 2006 My father passed away the day after Thanksgiving at the age of 69. An incredibly difficult time. He passed away that morning of a heart attack. They say it hit him so quick, that he was basically dead when he hit the floor. Although we didn’t often show it, we were quite close. This one hurts! At least we got to have one more holiday with him. Also earlier this year (2007) we lost one of me & Mary’s closest friends and former caregivers. She is sorely missed. As of Feb. 1 of 2007 I have left my former homecare providers and have a private individual doing my homecare. A good friend and a skilled caregiver. I still need to find someone to cover her days off, but it’s damn hard to find people that are as good as her. Also, The love of my life, my wife Mary had a heart attack March 3rd, 2007. They wound up putting in a steint to solve a narrowed artery in her... (more)

2013 Reading in Review

I was planning on taking a very, very long road to assembling the graphic below, but I am glad I did some research first. It saved me from learning how to create WordPress plugins, or toying around with the Goodreads API, which I will most likely still do at some point. It was a great year for my reading. 89 books, graphics novels, Audible, etc. I plan to bump it up even more in 2014. Below the image, I have pulled in the more in depth reviews of the books in descending order based on my star ratings. .gr_custom_container_1388710762 { /* customize your Goodreads widget container here*/ border: 0px solid gray; border-radius:10px; padding: 10px 5px 10px 5px; background-color: #ffffff; color: #000000; } .gr_custom_header_1388710762 { /* customize your Goodreads header here*/ border-bottom: 1px solid gray; width: 100%; margin-bottom: 5px; text-align: center; font-size... (more)

Deconstructing the '2014 State of Devops' Report

There is a very famous maxim in statistics - correlation does not imply causation. If you Google 'interesting correlations', you'll see that correlations have been established between ice cream consumption and murder, pirate shortage and global warming, organic food and autism, internet explorer and murder (this one is not so surprising ), obesity and the debt bubble and many other such extremely disconnected phenomenon. Having said that, the reverse is also true - correlation does not imply no causation. Moreover, there is this entire universe of literature available on 'cognitive biases' - we see what we want to see and we  hear what we want to hear - but that's a topic for another day. Why all this? Well, went through the "2014 State of Devops' Report - recently co-published by PuppetLabs, ThoughtWorks and the IT  Revolution Press. With distinguished names like Gen... (more)

IRN Payment Systems Gives up Some of Its Profits to Help Charities Through Its Revolutionary New Program Called The Hope Process

WESTBURY, N.Y., March 3 /PRNewswire/ -- IRN Payment Systems (IRN), a leader in the credit card processing industry, announced a revolutionary program designed to provide charitable organizations with a steady stream of donations. Named "The Hope Process," the program enables IRN's customers to donate to charities based on a percentage of their credit card processing fees that would normally be collected by IRN as profit. "As a father of an Autistic child, I learned the importance of charitable giving," said Dino Sgueglia President and Founder of IRN Payment Systems. "I wanted to be directly involved in supporting those with Autism, so I created Danny's Wish, an organization named after my son that was established to provide funds for Autistic services and charities. However, in creating Danny's Wish, I realized the difficulties all charities have in maintaining ... (more)

Texas Children's Fetal Center Performs Successful Fetal Surgery to Treat Spina Bifida

HOUSTON, Feb. 23, 2012 /PRNewswire-USNewswire/ -- As one of the country's leading medical centers diagnosing and treating fetal anomalies, Texas Children's Fetal Center is proud to announce the birth of Baby Charlotte, the team's first patient to undergo in-utero surgery for the treatment of spina bifida. Baby Charlotte's mother went into labor nearly 11 weeks after fetal closure was performed, and delivered on Saturday evening by cesarean section.  Mother and baby are doing well.  (Photo: http://photos.prnewswire.com/prnh/20120223/DC58641) "Texas Children's Fetal Center is now one of the very few centers in the country providing all aspects of fetal surgery, and the addition of this capability increases the options of our Texas and regional patients tremendously," said Dr. Michael Belfort, MD, Ph.D., obstetrician and gynecologist-in-chief at Texas Children's Hospit... (more)

Cellceutix Novel Anti-Cancer Compound Kevetrin(TM) Presented at American Association for Cancer Research Annual Meeting

BEVERLY, MA -- (Marketwire) -- 04/04/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a biopharmaceutical company developing small molecule drugs to treat severe medical conditions, including drug-resistant cancers, is pleased to provide shareholders an update on developments with its novel anti-cancer compound Kevetrin™. On Sunday, April 1, 2012, Cellceutix presented a poster on the potent anti-tumor effects in several wild type and mutant p53 human tumor xenografts at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, IL. The poster, entitled "Kevetrin™ targets both MDM2-p53 and Rb-E2F pathways in tumor suppression," was well-received and sparked conversation with the world's leading biotechnology companies as they stopped to discuss the upcoming clinical trials for Kevetrin™ with Cellceutix Chief Scientific Officer Dr. Kris... (more)

Kessler Foundation Names John O'Neill, PhD, to Rehabilitation Research Team

WEST ORANGE, NJ -- (Marketwire) -- 06/13/12 -- Kessler Foundation appointed John O'Neill, PhD, CRC, as vocational rehabilitation researcher, an inaugural position. Dr. O'Neill's expertise broadens the scope of the Foundation's rehabilitation research in mobility and cognition to include employment outcomes. He assumes the position in July 2012. Rodger DeRose, president and chief executive officer of Kessler Foundation, said, "The addition of Dr. O'Neill will further integrate employment considerations in our rehabilitation research. Restoring function is important but getting individuals with disabilities back to employment is crucial to self-sufficiency and community integration." Dr. O'Neill, formerly of Hunter College of the City University of New York, has more than 30 years of experience in vocational rehabilitation research. He is a noted expert in how culture... (more)

Research and Markets: People Monitoring and Safety Solutions - Family Locator Services to Reach 70 Million Active Users in Europe and North America By 2016

Research and Markets (http://www.researchandmarkets.com/research/tmtjqp/people_monitoring) has announced the addition of Berg Insight AB's new report "People Monitoring and Safety Solutions" to their offering. According to a new research report from the analyst firm Berg Insight, the number of active users of family locator services in Europe and North America is forecasted to grow from 16 million in 2011 at a compound annual growth rate (CAGR) of 34 percent to reach 70 million in 2016. In terms of number of users, family locator services is the largest segment for people monitoring and safety solutions based on either GPS-enabled smartphones or dedicated cellular/GPS location devices. Many parents are now discovering free and low cost apps that can turn a smartphone into a location device that enable monitoring of family members such as children or elderly. Growin... (more)

New First-in-class Treatment Fycompa® Launches in Norway for Most Common Form of Epilepsy

HATFIELD, England, January 7, 2013 /PRNewswire/ -- Eisai today launches Fycompa® (perampanel) in Norway as a treatment for partial-onset seizures, with or without secondarily generalised seizures, in people with epilepsy aged 12 years and older.[1]  Perampanel is the first in an entirely new class of treatment for uncontrolled partial epilepsy, the most common form of the condition. There are more than 45,000 people in Norway with epilepsy.[2] The successful treatment of partial-onset seizures remains a significant challenge in some patients and the incidence of uncontrolled partial epilepsy remains high despite the availability of many anti-epileptic drugs (AEDs). Currently, between 20 - 40% of patients with newly diagnosed epilepsy will become refractory to treatment.[3] Perampanel is the first and only licensed AED to selectively target AMPA receptors, a protein... (more)